We investigated cognitive impairment in rats caused by status epilepticus (SE).
Deficits in a novel object recognition task developed 6–12 weeks after SE.
Treatment with the EP2 antagonist TG6-10-1 after SE blocked the memory impairment.
TG6-10-1 did not affect behavioral changes in the light-dark box and open field assays.
TG6-10-1 is not an acute anticonvulsant as it did not alter acute seizure characteristics.